IL99536A - Isoprenoid phospholipase A2 inhibitors and pharmaceutical preparation comprising them - Google Patents
Isoprenoid phospholipase A2 inhibitors and pharmaceutical preparation comprising themInfo
- Publication number
- IL99536A IL99536A IL9953691A IL9953691A IL99536A IL 99536 A IL99536 A IL 99536A IL 9953691 A IL9953691 A IL 9953691A IL 9953691 A IL9953691 A IL 9953691A IL 99536 A IL99536 A IL 99536A
- Authority
- IL
- Israel
- Prior art keywords
- compound
- pharmaceutical preparation
- inflammation
- preparation
- mammal
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C63/00—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
- C07C63/64—Monocyclic acids with unsaturation outside the aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
- C07C403/20—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by carboxyl groups or halides, anhydrides, or (thio)esters thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/09—Geometrical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/586,159 US5141959A (en) | 1990-09-21 | 1990-09-21 | Isoprenoid phospholipase a2 inhibitors and preparations comprising same |
Publications (2)
Publication Number | Publication Date |
---|---|
IL99536A0 IL99536A0 (en) | 1992-08-18 |
IL99536A true IL99536A (en) | 1995-10-31 |
Family
ID=24344545
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL9953691A IL99536A (en) | 1990-09-21 | 1991-09-20 | Isoprenoid phospholipase A2 inhibitors and pharmaceutical preparation comprising them |
Country Status (18)
Country | Link |
---|---|
US (1) | US5141959A (es) |
EP (1) | EP0476682B1 (es) |
JP (1) | JP2943089B2 (es) |
AT (1) | ATE117979T1 (es) |
AU (1) | AU637756B2 (es) |
CA (1) | CA2051766A1 (es) |
DE (1) | DE69107153T2 (es) |
DK (1) | DK0476682T3 (es) |
ES (1) | ES2067822T3 (es) |
FI (1) | FI104168B (es) |
GR (1) | GR3014944T3 (es) |
IE (1) | IE66745B1 (es) |
IL (1) | IL99536A (es) |
MX (1) | MX9101163A (es) |
NZ (1) | NZ239844A (es) |
OA (1) | OA09514A (es) |
PT (1) | PT99014B (es) |
ZA (1) | ZA917531B (es) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7189737B2 (en) * | 1991-08-09 | 2007-03-13 | Research Triangle Institute | Cocaine receptor binding ligands |
US5688781A (en) * | 1994-08-19 | 1997-11-18 | Bristol-Myers Squibb Company | Method for treating vascular leak syndrome |
FR2735371B1 (fr) * | 1995-06-19 | 1997-07-18 | Cird Galderma | Procede pour identifier des composes antagonistes des recepteurs rars |
US6900228B1 (en) * | 1998-03-10 | 2005-05-31 | Research Triangle Institute | Opiate compounds, methods of making and methods of use |
US6267945B1 (en) * | 1998-12-18 | 2001-07-31 | Neuromed Technologies, Inc. | Farnesol-related calcium channel blockers |
US6538010B1 (en) * | 2000-11-08 | 2003-03-25 | Research Triangle Institute | Compounds and methods for promoting smoking cessation |
US7842727B2 (en) * | 2001-03-27 | 2010-11-30 | Errant Gene Therapeutics, Llc | Histone deacetylase inhibitors |
US6495719B2 (en) * | 2001-03-27 | 2002-12-17 | Circagen Pharmaceutical | Histone deacetylase inhibitors |
US7312247B2 (en) * | 2001-03-27 | 2007-12-25 | Errant Gene Therapeutics, Llc | Histone deacetylase inhibitors |
US8026280B2 (en) | 2001-03-27 | 2011-09-27 | Errant Gene Therapeutics, Llc | Histone deacetylase inhibitors |
WO2003099272A1 (en) * | 2002-05-22 | 2003-12-04 | Errant Gene Therapeutics, Llc | Histone deacetylase inhibitors based on alpha-ketoepoxide compounds |
AU2003237397A1 (en) * | 2002-06-04 | 2003-12-19 | Sequenom, Inc. | Diagnosing predisposition to fat deposition and therapeutic methods for reducing fat deposition and treatment of associated conditions |
EP1581095A4 (en) * | 2002-06-27 | 2006-10-18 | Harkness Pharmaceuticals Inc | THERAPEUTIC METHODS FOR REDUCING FAT DEPOSIT AND TREATING THE DISEASES THEREOF |
AU2003248793A1 (en) * | 2002-06-27 | 2004-01-19 | Sequenom, Inc | Diagnosing predisposition to fat deposition and associated condition |
JP2006508986A (ja) * | 2002-11-20 | 2006-03-16 | エルラント ゲネ セラペウチクス エルエルシー | ヒストンデアセチラーゼ阻害剤による肺細胞の治療方法 |
CA2587013A1 (en) * | 2004-11-08 | 2006-05-18 | Errant Gene Therapeutics, Llc | Histone deacetylase inhibitors |
US7872023B2 (en) * | 2005-02-17 | 2011-01-18 | Research Triangle Institute | Kappa opioid receptor ligands |
US7399762B2 (en) * | 2005-04-25 | 2008-07-15 | Research Triangle Institute | Opioid receptor agonist compounds and their use in treatment of pain |
US7476679B2 (en) * | 2005-07-26 | 2009-01-13 | Research Triangle Institute | Octahydroisoquinoline compounds as opioid receptor modulators |
EP2076124A4 (en) * | 2007-04-20 | 2011-08-03 | Acucela Inc | STYRENYL DERIVATIVE COMPOUNDS FOR THE TREATMENT OF OPHTHALMOLOGICAL DISEASES AND SUFFERING |
US8048895B2 (en) * | 2008-04-18 | 2011-11-01 | Research Triangle Institute | Kappa opioid receptor ligands |
US9273027B2 (en) | 2010-02-24 | 2016-03-01 | Research Triangle Institute | Arylpiperazine opioid receptor antagonists |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4194007A (en) * | 1978-01-13 | 1980-03-18 | Scott Eugene J Van | α-Hydroxyretinoic acid, α-ketoretinoic acid and mixtures and their use in treating skin conditions |
US4456618A (en) * | 1982-10-15 | 1984-06-26 | Sri International | Naphthenic and heterocyclic retinoic acid analogues |
US4568757A (en) * | 1984-01-30 | 1986-02-04 | Research Triangle Institute | Configurationally locked retinoids |
-
1990
- 1990-09-21 US US07/586,159 patent/US5141959A/en not_active Expired - Fee Related
-
1991
- 1991-09-18 CA CA002051766A patent/CA2051766A1/en not_active Abandoned
- 1991-09-18 NZ NZ239844A patent/NZ239844A/xx unknown
- 1991-09-19 PT PT99014A patent/PT99014B/pt not_active IP Right Cessation
- 1991-09-19 OA OA60073A patent/OA09514A/en unknown
- 1991-09-19 MX MX9101163A patent/MX9101163A/es not_active IP Right Cessation
- 1991-09-19 FI FI914405A patent/FI104168B/fi active
- 1991-09-20 ES ES91116015T patent/ES2067822T3/es not_active Expired - Lifetime
- 1991-09-20 IL IL9953691A patent/IL99536A/en active IP Right Grant
- 1991-09-20 IE IE331891A patent/IE66745B1/en not_active IP Right Cessation
- 1991-09-20 EP EP91116015A patent/EP0476682B1/en not_active Expired - Lifetime
- 1991-09-20 DK DK91116015.8T patent/DK0476682T3/da active
- 1991-09-20 AU AU84626/91A patent/AU637756B2/en not_active Ceased
- 1991-09-20 ZA ZA917531A patent/ZA917531B/xx unknown
- 1991-09-20 AT AT91116015T patent/ATE117979T1/de not_active IP Right Cessation
- 1991-09-20 JP JP3313021A patent/JP2943089B2/ja not_active Expired - Fee Related
- 1991-09-20 DE DE69107153T patent/DE69107153T2/de not_active Expired - Fee Related
-
1995
- 1995-02-02 GR GR940403510T patent/GR3014944T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
AU8462691A (en) | 1992-03-26 |
MX9101163A (es) | 1992-05-04 |
IL99536A0 (en) | 1992-08-18 |
DE69107153D1 (de) | 1995-03-16 |
ATE117979T1 (de) | 1995-02-15 |
IE66745B1 (en) | 1996-02-07 |
FI104168B1 (fi) | 1999-11-30 |
IE913318A1 (en) | 1992-02-25 |
DE69107153T2 (de) | 1995-05-24 |
NZ239844A (en) | 1993-04-28 |
ZA917531B (en) | 1992-07-29 |
OA09514A (en) | 1992-11-15 |
FI914405A0 (fi) | 1991-09-19 |
GR3014944T3 (en) | 1995-05-31 |
JP2943089B2 (ja) | 1999-08-30 |
JPH04270261A (ja) | 1992-09-25 |
AU637756B2 (en) | 1993-06-03 |
US5141959A (en) | 1992-08-25 |
FI104168B (fi) | 1999-11-30 |
EP0476682B1 (en) | 1995-02-01 |
FI914405A (fi) | 1992-03-22 |
PT99014B (pt) | 1999-02-26 |
ES2067822T3 (es) | 1995-04-01 |
EP0476682A1 (en) | 1992-03-25 |
CA2051766A1 (en) | 1992-03-22 |
DK0476682T3 (da) | 1995-04-03 |
PT99014A (pt) | 1992-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0476682B1 (en) | Isoprenoid phospholipase A2 inhibitors and preparations comprising same | |
US5607966A (en) | Esters and amides of non-steroidal anti-inflammatory carboxylic acids which may be used as anti-oxidants, 5-lipoxygenase inhibitors and non-steroidal anti-inflammatory prodrugs | |
AU673998B2 (en) | Antipyretic and analgesic methods and compositions containing optically pure R(-) ketoprofen | |
US4826984A (en) | Heteroarotinoid compounds as anticancer agents | |
JP2008531558A (ja) | 新規なリポオキシゲナーゼ阻害剤 | |
EP0407200A1 (en) | Cinnamamide derivatives | |
AU3032099A (en) | Retinoid antagonists and use thereof | |
US6740676B2 (en) | 4-[(8-ethynyl, 8-vinyl or 8-ethynyl-methyl)-6-chromanoyl]-benzoic and 2-[4-[(8-ethynyl, 8-vinyl or 8-ethynyl-methyl)-6-chromanoyl]-phenyl]-acetic acid, their esters and salts having cytochrome p450rai inhibitory activity | |
CA2512563C (en) | Kynurenine 3-hydroxylase inhibitors for the treatment of diabetes | |
US4025649A (en) | Acetic acid derivatives having pharmacological activity and compositions containing the same | |
US7019034B2 (en) | Compositions and methods for reducing serum glucose and triglyceride levels in diabetic mammals | |
US4778818A (en) | Substituted 2-(heteroaryl-2-propenyl)phenols useful as anti-inflammatory agents | |
FR2521992A1 (fr) | Nouveaux composes de pyridine utiles comme medicaments | |
US4469705A (en) | Saturated leukotriene derivatives as antiallergens | |
JP2754644B2 (ja) | 新規リグナン類およびリグナン類を有効成分とする5―リポキシゲナーゼ阻害剤およびアルドースリダクターゼ阻害剤 | |
HU211590A9 (hu) | Izoprenoidvázas foszfolipáz A2 gátló vegyületek és az ezeket tartalmazó gyógyászati készítmények Az átmeneti oltalom az 1., 2. és 8-11. igénypontokra vonatkozik. | |
JP2003026636A (ja) | 脂質代謝系酵素を阻害するチロゾール誘導体 | |
JPH08502521A (ja) | 10−置換 1,8−ジヒドロキシ−9(10h)アントラセノン医薬 | |
JP3144662B2 (ja) | スチルベン誘導体とスチルベン同族体誘導体及びそれらの用途 | |
US20180185325A1 (en) | 12H-BENZO[b]XANTHEN-12-ONES, COMPOSITIONS CONTAINING, AND USES OF, SAME | |
EP0504017A1 (fr) | Dérivés du benzopyrane, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent | |
US20040077721A1 (en) | Compositions and methods using compounds having cytochrome P450RAI inhibitory activity co-administered with vitamin A | |
US6331570B1 (en) | Active enantiomer of RARγ-specific agonist | |
CA2387164A1 (fr) | Composes anti-ischemiques | |
EP0395526A1 (fr) | Nouveaux dérivés benzothiazolinoniques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed |